相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An insight into the binding mechanism of Viprinin and its morpholine and piperidine derivatives with HIV-1 Vpr: molecular dynamics simulation, principal component analysis and binding free energy calculation study
Satyabrata Majumder et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
Jerome Eberhardt et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naive patients: A single-centre experience
Laura Mazzuti et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019)
Zhaojie Yang et al.
ARCHIVES OF VIROLOGY (2020)
Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity
Elliot D. Drew et al.
BMC MOLECULAR AND CELL BIOLOGY (2020)
HIV subtype diversity worldwide
Nicholas Bbosa et al.
CURRENT OPINION IN HIV AND AIDS (2019)
Viral protein R inhibitors from Swertia chirata of Myanmar
So-Yeun Woo et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2019)
Distinct Requirements for HIV-1 Accessory Proteins during Cell Coculture and Cell-Free Infection
Anastasia Zotova et al.
VIRUSES-BASEL (2019)
Human immunodeficiency virus type 1 ((HIV-1) subtypes in the northwest region, Cameroon
Lem Edith Abongwa et al.
VIROLOGY JOURNAL (2019)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention
Maria Eugenia Gonzalez
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran
Reza Golmohammadi et al.
INTERVIROLOGY (2017)
Naturally occurring Vpr inhibitors from medicinal plants of Myanmar
Nwet Nwet Win et al.
JOURNAL OF NATURAL MEDICINES (2017)
HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China
Xinli Lu et al.
AIDS RESEARCH AND THERAPY (2017)
HIV-1 Subtype Diversity and Prevalence of Primary Drug Resistance in a Single-Center Pediatric Cohort in Germany
Jennifer Neubert et al.
INTERVIROLOGY (2016)
Calculating protein-ligand binding affinities with MMPBSA: Method and error analysis
Changhao Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2016)
Molecular Mechanism of HIV-1 Vpr for Binding to Importin-α
Hideyuki Miyatake et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
Ying Wu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Human Immunodeficiency Virus (HIV)
Lutz Gurtler et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
Ying Wu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa
Colin M. Venner et al.
EBIOMEDICINE (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models
Martin K. Scherer et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins
Dima Kozakov et al.
NATURE PROTOCOLS (2015)
HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation
Jonathan M. O. Rawson et al.
RETROVIROLOGY (2015)
Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor
Kyoji Hagiwara et al.
PLOS ONE (2015)
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin et al.
CHEMISTRY & BIOLOGY (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Building Water Models: A Different Approach
Saeed Izadi et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2014)
HIV-1 Vpr-a still enigmatic multitasker
Carolin A. Guenzel et al.
FRONTIERS IN MICROBIOLOGY (2014)
Pocket-Based Drug Design: Exploring Pocket Space
Xiliang Zheng et al.
AAPS JOURNAL (2013)
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
Ana B. Abecasis et al.
RETROVIROLOGY (2013)
HIV accessory proteins versus host restriction factors
Klaus Strebel
CURRENT OPINION IN VIROLOGY (2013)
Current trends of HIV recombination worldwide
Katherine A. Lau et al.
INFECTIOUS DISEASE REPORTS (2013)
The structural biology of HIV-1: mechanistic and therapeutic insights
Alan Engelman et al.
NATURE REVIEWS MICROBIOLOGY (2012)
HIV Transmission
George M. Shaw et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
HIV-1 Antiretroviral Drug Therapy
Eric J. Arts et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy
B. Chaplin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Antiretroviral Therapy for HIV: Do Subtypes Matter?
Jose M. Gatell
CLINICAL INFECTIOUS DISEASES (2011)
Vpr-Host Interactions During HIV-1 Viral Life Cycle
Richard Y. Zhao et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
HIV-1 Accessory Protein Vpr: Relevance in the pathogenesis of HIV and potential for therapeutic intervention
Michael Kogan et al.
RETROVIROLOGY (2011)
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques
Ryan Brenke et al.
BIOINFORMATICS (2009)
Fpocket: An open source platform for ligand pocket detection
Vincent Le Guilloux et al.
BMC BIOINFORMATICS (2009)
Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
Anna Maria Geretti et al.
CLINICAL INFECTIOUS DISEASES (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets
Catherine S. Adamson et al.
MOLECULAR INTERVENTIONS (2009)
Challenges in the development of an HIV-1 vaccine
Dan H. Barouch
NATURE (2008)
Medical progress: The challenge of HIV-1 subtype diversity
Barbara S. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antiretroviral drug development: the challenge of cost and access
Michael Dunne
AIDS (2007)
Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death
Masakazu Kamata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration
R Kantor et al.
PLOS MEDICINE (2005)
Drug resistance in non-subtype BHIV-1
R Kantor et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
An approach to developing a force field for molecular simulation of martensitic phase transitions between phases with subtle differences in energy and structure
SC Tuble et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
NMR structure of the HIV-1 regulatory protein VPR
N Morellet et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Evidence for a cytopathogenicity determinant in HIV-1 Vpr
M Somasundaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Electrostatics of nanosystems: Application to microtubules and the ribosome
NA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
MM Addo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
